Aussie Healthcare Daily: 8 Dec 2017
The Aussie Healthcare Daily is a summary of major news and announcements from ASX-listed healthcare companies as well as developments and trends in...
197 Views
Aussie Healthcare Daily: 5 Dec 2017
The Aussie Healthcare Daily is a summary of major news and announcements from ASX-listed healthcare companies as well as developments and trends in...
160 Views
Lead Heart Trial Beats Faster for Mesoblast; Interim Analysis Encouraging
We are raising our fair value estimate to AUD 2.80 per share from AUD 2.30 for no-moat Mesoblast Ltd (MSB AU), following the encouraging interim...
144 Views
Longs & Shorts from Sohn Sydney Conference
With all the political excitement last week, the first Sohn Sydney conference on 11th November does not appear to have received much airtime within...
368 Views
Current Share Price Ascribes No Value to Chronic Heart Failure Potential, but Risk Still Very High
We maintain our risk-adjusted DCF-based fair value estimate for Mesoblast of A$6 per share and reiterate our no-moat and very high uncertainty...
190 Views